Deepak Kumar to MicroRNAs
This is a "connection" page, showing publications Deepak Kumar has written about MicroRNAs.
Connection Strength
3.040
-
Rios-Colon L, Chijioke J, Niture S, Afzal Z, Qi Q, Srivastava A, Ramalinga M, Kedir H, Cagle P, Arthur E, Sharma M, Moore J, Deep G, Suy S, Collins SP, Kumar D. Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks. Sci Rep. 2022 06 16; 12(1):10073.
Score: 0.498
-
Niture S, Tricoli L, Qi Q, Gadi S, Hayes K, Kumar D. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. Tumour Biol. 2022; 44(1):107-127.
Score: 0.483
-
Ge X, Niture S, Lin M, Cagle P, Li PA, Kumar D. MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8. Sci Rep. 2021 03 11; 11(1):5660.
Score: 0.456
-
Rios-Colon L, Deep G, Kumar D. Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases. Tumour Biol. 2019 Oct; 41(10):1010428319881344.
Score: 0.413
-
Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Rios-Colon L, Chimeh U, Suy S, Collins SP, Dahiya R, Kumar D. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells. Sci Rep. 2019 07 05; 9(1):9776.
Score: 0.406
-
Tricoli L, Niture S, Chimeh U, Ressom H, Kumar D. Role of microRNAs in the development of hepatocellular carcinoma and drug resistance. Front Biosci (Landmark Ed). 2019 01 01; 24(2):382-391.
Score: 0.392
-
Tricoli L, Niture S, Chimeh U, Kumar D. Role of microRNAs in the development of hepatocellular carcinoma and acquired drug resistance. Front Biosci (Landmark Ed). 2019 01 01; 24(3):545-554.
Score: 0.392